William Dai is new CFO of ShangPharma Corp.

ShangPharma Corporation has appointed William Dai as chief financial officer, effective January 10, 2011. Kevin Penghui Chen, ShangPharma's former CFO and chief operating officer will become president of the company and continue his role as COO.


Dai has more than 17 years of experience in accounting, financial management, and the capital markets. Prior to ShangPharma, Dai served as CFO of the New York Stock Exchange-listed China Nepstar Chain Drugstore Ltd. in Shenzhen, China since January 2009. From 2006 to 2008, Dai was the CFO and vice chair of the Executive Committee at MicroPort Medical Co. Ltd. in Shanghai, China. From 1993 to 2005, Dai held a variety of financial and senior managerial roles at multinational companies in China and the United States.


Dai holds a master's degree in business administration with an emphasis in finance from Michigan State University, and a bachelor's degree in international business and English from Shanghai University's College of International Business in Shanghai, China.

Suggested Articles

Some of you might have already been aware of the news that Questex—with the aim to focus on event business—will shut down permanently all media brands in Asia…

Some advice for transitioning into an advisory role

Global risks are intensifying but the collective will to tackle them appears to be lacking. Check out this report for areas of concern